Malaria drug combo study halted early
NCT ID NCT04080895
First seen Jan 12, 2026 · Last updated Apr 29, 2026 · Updated 15 times
Summary
This study aimed to see how two malaria medicines (artemether-lumefantrine and amodiaquine) interact in healthy adults. It was an early-stage trial with only 8 participants and was stopped before completion. The main goal was to measure drug levels in the blood to understand safety and dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Tropical Medicine, Mahidol University
Bangkok, 10400, Thailand
Conditions
Explore the condition pages connected to this study.